Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Recent studies have shown important roles for activation-induced cytidine deaminase (AID), an intrinsic genome mutator, in H. pylori-associated gastric cancer development. Here, we evaluated the relationship between H. pylori-induced gastritis and AID expression from human biopsy specimens.
In 109 patients with dyspeptic symptoms who had undergone endoscopy and received biopsy of the antrum, angulus, and corpus, H. pylori infection was diagnosed by serologic test, 13C urea breath test, and histological examination. Histological scores of H. pylori, neutrophils, mononuclear cells, atrophy, and intestinal metaplasia (IM) were assessed using the updated Sydney system (USS). Immunohistochemical AID expression of the biopsy specimens was scored.
Sixty of 109 (55.0 %) patients were positive for H. pylori and eradication was successful in 48 patients. AID expression in H. pylori-infected mucosa was significantly higher (p < 0.01) than in non-infected mucosa. AID expression was highest in the antrum and was significantly (p < 0.01) reduced toward the proximal portion of the stomach. For USS, multivariate analysis using linear regression revealed that mononuclear cell infiltration (p < 0.01) and IM (p < 0.05) correlated independently with AID expression. After eradication of H. pylori, AID expression was significantly decreased (p < 0.01), but was still higher than that in H. pylori-negative patients in all sites of the stomach.
AID expression is elevated in H. pylori-positive patients and is reduced following H. pylori eradication. Moreover, AID expression is highest in the antrum and correlated with severity of chronic inflammation and IM, suggesting an important role for AID in gastric cancer development through gastritis.
- Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273–75.
- Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127–131.
- Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
- Correa P. Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomark Prev. 2003;12:238s–41s.
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81. CrossRef
- Rugge M, Genta RM, OLGA Group. Staging gastritis: an international proposal. Gastroenterology. 2005;129:1807–8. CrossRef
- Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–6. CrossRef
- Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71:1150–8. CrossRef
- Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2009;14(Suppl 1):15–20. CrossRef
- Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009;44:239–48. CrossRef
- Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143:550–63. CrossRef
- Touati E, Michel V, Thiberge JM, et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology. 2003;124:1408–19. CrossRef
- Matsumoto Y, Marusawa H, Kinoshita K, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13:470–6. CrossRef
- Matsumoto Y, Marusawa H, Kinoshita K, et al. Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b–CDKN2a in gastric cancer. Gastroenterology. 2010;139:1984–94. CrossRef
- Marusawa H, Chiba T. Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr Opin Immunol. 2010;22:442–7. CrossRef
- Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7. CrossRef
- Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74. CrossRef
- Sim J, Wright CC. The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther. 2005;85:257–68.
- Shimizu T, Marusawa H, Endo Y. Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis. Cancer Sci. 2012;103:1201–6. CrossRef
- Takeda Y, Yashima K, Hayashi A, et al. Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer. World J Gastrointest Oncol. 2012;4:131–7. CrossRef
- Goto A, Hirahashi M, Osada M, et al. Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer. Virchows Arch. 2011;458:717–24. CrossRef
- van Den Brink GR, ten Kate FJ, Ponsioen CY, et al. Expression and activation of NF-kappa B in the antrum of the human stomach. J Immunol. 2000;164:3353–9.
- Pathak SK, Basu S, Bhattacharyya A, et al. TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol. 2006;177:7950–8.
- Yamauchi K, Choi IJ, Lu H, et al. Regulation of IL-18 in Helicobacter pylori infection. J Immunol. 2008;180:1207–16.
- Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13:2–9. CrossRef
- Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol. 1993;28:924–8. CrossRef
- Kim CJ, Song JH, Cho YG, et al. Activation-induced cytidine deaminase expression in gastric cancer. Tumour Biol. 2007;28:333–9. CrossRef
- Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to campylobacter pylori? J Clin Pathol. 1989;42:1269–71. CrossRef
- Naylor GM, Gotoda T, Dixon M, et al. Why does japan have a high incidence of gastric cancer? comparison of gastritis between UK and japanese patients. Gut. 2006;55:1545–52. CrossRef
- Matsuhisa T, Tsukui T. Relation between reflux of bile acids into the stomach and gastric mucosal atrophy, intestinal metaplasia in biopsy specimens. J Clin Biochem Nutr. 2012;50:217–21. CrossRef
- Morita S, Matsumoto Y, Okuyama S, et al. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett’s oesophageal adenocarcinoma. Carcinogenesis. 2011;32:1706–12. CrossRef
- Olearchyk AS. Gastric carcinoma. A critical review of 243 cases. Am J Gastroenterol. 1978;70:25–45.
- Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151:121–8. CrossRef
- Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365–71. CrossRef
- Ushijima T, Nakajima T, Maekita T. DNA methylation as a marker for the past and future. J Gastroenterol. 2006;41:401–7. CrossRef
- Tatemichi M, Hata H, Nakadate T. Ectopic expression of activation-induced cytidine deaminase caused by epigenetics modification. Oncol Rep. 2011;25:153–8.
- Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication
Journal of Gastroenterology
Volume 49, Issue 3 , pp 427-435
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Activation-induced cytidine deaminase
- Helicobacter pylori
- Updated Sydney system
- Intestinal metaplasia
- Endoscopic biopsy
- Industry Sectors
- Author Affiliations
- 1. Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine (NCGM), 1-21-1 Toyama, Shinjuku-ku, Tokyo, 162-8655, Japan
- 4. Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan
- 2. Department of Clinical Research and Informatics, International Clinical Research Center Research Institute, National Center for Global Health and Medicine, Tokyo, Japan
- 3. Department of Clinical Pathology, National Center for Global Health and Medicine, Tokyo, Japan
- 5. Pathology and Cytology Laboratories (PCL), Tokyo, Japan
- 6. Department of Gastroenterology and Hepatology, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan